header image

Haematology

These plasma derived products are produced to the highest standards, using the latest technology, in state-of-the-art manufacturing facilities to ensure the most advanced therapies are available to patients globally. 

nuwiq®

Nuwiq®, human cell line recombinant factor VIII (simoctocog alfa) is a purified protein for the treatment and prophylaxis of bleeding in previously treated paediatric (≥ 2 years) and adult patients with haemophilia A (congenital factor VIII [FVIII] deficiency). The amino acid sequence is comparable to the 90 + 80 kDa form of human plasma factor VIII (i.e. B-domain deleted). Nuwiq® is produced by recombinant DNA technology in genetically modified human embryonic kidney (HEK) 293F cells. No animal or human derived materials are added during the manufacturing process or to the final medicinal product.

 

Nuwiq® is  only available on a doctor's prescription. 

 

For more information on Nuwiq®, please contact us.

octanate®

Human Coagulation Factor VIII concentrate

Powder and solvent for solution for injection. It is used to treat patients with haemophilia A, a bleeding disorder, in which there are reduced levels of the clotting factor called factor VIII.

 

octanate is only available on a doctor's prescription.

 

For more information on octanate, please contact us.

wilate®

Human Coagulation Factor VIII and von Willebrand Factor (VWF) concentrate

Powder and solvent for solution for injection. It is used  to treat patients with haemophilia A, a bleeding disorder, in which there are reduced levels of the clotting factor called factor VIII, and in patients with von Willebrand disease, another type of bleeding disorder caused by defective or deficient von Willebrand factor.

 

wilate is only available on a doctor's prescription.

 

For further information on wilate, please contact us.